Vanguard Group
JUNS

Vanguard Group’s Jupiter Neurosciences JUNS Stock Holding History

Vanguard Group’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$254K Buy
3,319
+441
+15% +$44K ﹤0.01% 4073
2025
Q3 		$380K Buy
+2,878
New +$327K ﹤0.01% 4008

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.41B AUM

Vanguard Group's JUNS Position: Q4 2025 in Review

Vanguard Group increased its Jupiter Neurosciences (JUNS) stake by 15% in Q4 2025, buying an estimated $44K and bringing the position to 3,319 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #4073.

Vanguard Group first reported a position in JUNS in Q3 2025 and has held it in 2 quarters since. The position peaked at $380K in Q3 2025. 12 funds tracked by Wall St. Rank hold JUNS as of Q4 2025.

  • Vanguard Group held 3,319 shares of Jupiter Neurosciences worth $254K as of Q4 2025.
  • Vanguard Group bought 441 Jupiter Neurosciences shares in Q4 2025, an estimated $44K.
  • Jupiter Neurosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4073 holding.
  • Vanguard Group first reported a position in Jupiter Neurosciences in Q3 2025 and has held it in 2 quarters since.
  • Vanguard Group's Jupiter Neurosciences position peaked at $380K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.